⌘K

Home/Filings/4/0001209191-19-028232

4//SEC Filing

Berger Dietmar 4

Accession 0001209191-19-028232

CIK 0001604464other

View on SEC.gov Company Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:32 PM ET

Size

4.8 KB

Accession

0001209191-19-028232

Insider Transaction Report

Form 4

Period: 2019-05-07

Atara Biotherapeutics, Inc.ATRA

Global Head of R&D

Transactions

Tax Payment
Common Stock
2019-05-07$33.46/sh−4,322$144,614→ 85,678 total

Footnotes (1)

[F1]Shares withheld to cover tax obligation from settlement of vested restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001739515

Filing Metadata

Form type: 4
Filed: May 7, 8:00 PM ET
Accepted: May 8, 4:32 PM ET
Size: 4.8 KB

View on SEC.gov